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Background: The purpose of this study was to determine and compare the test-retest reliability 
of quadriceps isokinetic endurance testing at two knee angular velocities in patients with chronic 
obstructive pulmonary disease (COPD).
Methods: After one familiarization session, 14 patients with moderate to severe COPD (mean 
age 65±4 years; forced expiratory volume in 1 second (FEV
1
) 55%±18% predicted) performed 
two quadriceps isokinetic endurance tests on two separate occasions within a 5–7-day interval. 
Quadriceps isokinetic endurance tests consisted of 30 maximal knee extensions at angular veloci-
ties of 90° and 180° per second, performed in random order. Test-retest reliability was assessed 
for peak torque, muscle endurance, work slope, work fatigue index, and changes in FEV
1
 for 
dyspnea and leg fatigue from rest to the end of the test. The intraclass correlation coefficient, 
minimal detectable change, and limits of agreement were calculated.
Results: High test-retest reliability was identified for peak torque and muscle total work at 
both velocities. Work fatigue index was considered reliable at 90° per second but not at 180° 
per second. A lower reliability was identified for dyspnea and leg fatigue scores at both angular 
velocities.
Conclusion: Despite a limited sample size, our findings support the use of a 30-maximal 
repetition isokinetic muscle testing procedure at angular velocities of 90° and 180° per second 
in patients with moderate to severe COPD. Endurance measurement (total isokinetic work) at 
90° per second was highly reliable, with a minimal detectable change at the 95% confidence level 
of 10%. Peak torque and fatigue index could also be assessed reliably at 90° per second. Evalu-
ation of dyspnea and leg fatigue using the modified Borg scale of perceived exertion was poorly 
reliable and its clinical usefulness is questionable. These results should be useful in the design 
and interpretation of future interventions aimed at improving muscle endurance in COPD.
Keywords: chronic obstructive pulmonary disease, lower limb, isokinetic endurance, test-
retest reliability
Introduction
Limb muscle dysfunction has important clinical and prognostic consequences in 
chronic obstructive pulmonary disease (COPD). In fact, reduced mass and weakness 
of the quadriceps have been associated with reduced survival in this disease.1–3 Muscle 
strength is the most commonly assessed skeletal muscle function in COPD. However, 
muscle strength represents only one aspect of muscle function, mostly reflecting the 
action of fast-twitch muscle fibers. Muscle endurance is defined as the ability to main-
tain a given task over a certain period of time, and it is determined by muscle fiber 
oxidative capacity, and the oxygen supply.4 In COPD, muscle endurance is impaired 
to a greater extent than strength.5,6 Impaired muscle endurance may even be present in 
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patients with mild disease and preserved physical activity,7,8 
and cannot be predicted from strength.7
Despite its relevance to activities of daily living such as 
walking,9,10 muscle endurance is generally not an outcome in 
COPD clinical trials.11 One important methodological issue with 
the measurement of muscle endurance is the fact that there is 
no standardization or agreement on a testing protocol that could 
be used in clinical practice or research. It can be determined 
with various methodologies, amongst which isokinetic testing 
is one of the most reliable methods.12 The main advantage of this 
method is that it provides a dynamic measurement of muscle 
torque while controlling for angular velocities, amplitude, and 
duration of movement in such a way that the testing conditions 
could be easily reproduced in subsequent testing.13
As with any other muscle function assessment, isokinetic 
endurance is required to be accurate and reliable. The reli-
ability of isokinetic testing has been reported for strength 
and endurance in healthy subjects.14,15 In COPD patients, 
although the reliability of isokinetic strength testing has been 
reported,16 little is known about the reliability of isokinetic 
endurance measurements at different angular velocities.
Based on the model developed by Walter et al17 and the 
clinical decision-making process inherent in exercise testing 
protocols described by Charter et al,18 we hypothesize that, for 
both velocities, muscle endurance and work fatigue indices 
would achieve a minimally acceptable value, defined by an 
intraclass coefficient (ICC) .0.6.17
The purpose of this study was to determine the test-retest reli-
ability and minimal detectable change (MDC) of 30-maximum 
repetition isokinetic endurance testing of the quadriceps 
performed at 90° and 180° per second regarding peak torque, 
muscle endurance, and fatigue in patients with COPD.
Materials and methods
subject characteristics
Patients with stable and moderate to severe stage COPD 
accordingly to the Global Initiative for Chronic Obstructive 
Lung Disease19 were recruited. All subjects were former 
smokers, physically inactive, and naïve to the isokinetic pro-
cedure. Exclusion criteria were: other medical conditions that 
could affect exercise testing (ie, neuromuscular and/or ortho-
pedic disorders, recent cancer, unstable cardiac disease, type 2 
diabetes, asthma), recent COPD exacerbations (,6 weeks), 
body mass index .35 kg/m2, rest hypoxemia (SpO
2
 ,90%) 
or oxygen therapy, regular practice of physical activity 
(Voorrips score .9),20 and involvement in a rehabilitation 
or structured exercise training program during the previous 
6 months. The research protocol was approved by the ethics 
committee of the Institut Universitaire de cardiologie et de 
pneumologie de Québec. All the subjects signed the informed 
consent before enrolment in the study.
study design
Study participation involved three visits. The first visit 
included a review of medical history, a Voorrips physical 
activity questionnaire, anthropometric measurements, pul-
monary function testing, and a familiarization session for the 
quadriceps isokinetic endurance test. During familiarization, 
subjects were asked to perform warm-up and endurance 
exercise measurements on the isokinetic dynamometer in 
the same fashion as required for the testing days (described 
below). The procedures and series of exercises were repeated 
as needed until performance was considered compatible with 
acceptable comprehension of the test.14,21 After 5–7 days, sub-
jects returned to the laboratory for the quadriceps isokinetic 
endurance testing protocol, which was repeated at a third visit 
performed 5–7 days later, as detailed in Figure 1.
The randomization plan was provided by software avail-
able online using the number of subjects to be included in the 
study (n=14) and the number of tests (n=2) performed.
Physical activity
In order to include subjects with a sedentary lifestyle, the 
level of physical activity in daily living was assessed with the 
Visit 2
Warm-up
Visit 3
Warm-up5–7 days 5–7 days
Isokinetic protocol 90° per
second*
Isokinetic protocol 180° per
second*
Isokinetic protocol 90° per
second*
Isokinetic protocol 180° per
second*
Visit 1
•  Medical history
•  Physical activity questionnaire
•  Anthropometric measurements
•  PFT
•  Familiarization session
Figure 1 experimental design.
Note: *randomized order.
Abbreviation: PFT, pulmonary function tests.
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activity questionnaire firstly devised by Baecke et al22 adapted 
for elderly subjects by Voorrips et al20 and used for patients 
with COPD.6 Subjects were considered sedentary whenever 
the global Voorrips score, which includes household, sport, 
and other leisure time physical activity, was lower than 9. 
None of the patients were enrolled in rehabilitation, exercise 
training, or physical activity programs during the 6 months 
prior to inclusion.
anthropometric data and body 
composition
Body composition was assessed by bioelectrical impedance 
analysis (TBF-300WA Tanita, Arlington Heights, IL, USA), 
which provides data on fat mass and fat-free mass. Fat-free mass 
index (FFMI) was calculated as FFMI = FFM/height2.23
Pulmonary function testing
Standard pulmonary function tests, including post-bron-
chodilator spirometry, lung volumes, and carbon monoxide 
diffusion capacity, were obtained in all subjects during the 
first visit according to previously described guidelines24–26 
and related to predicted normal values.27
assessment of quadriceps isokinetic 
endurance
All tests of the dominant knee extensors (quadriceps muscle 
action) were performed using an isokinetic dynamometer 
(System Pro 4, Biodex Medical Systems, Shirley, New York, 
NY, USA) and were conducted and recorded by the same 
investigator (FR). Subjects were positioned and stabilized 
on the dynamometer chair, as previously described.14,28 The 
knee joint center was aligned to the dynamometer axe cen-
ter. The lever arm of the dynamometer was firmly attached 
3 cm above the lateral malleolus. Total knee joint displace-
ment was fixed between 90° and 10° of knee flexion for all 
tests. Reference points for chair and lever arm positioning 
were annotated in order to ensure the same positioning dur-
ing subsequent visits. As a warm-up procedure, the subjects 
performed one series of ten submaximal knee extensions. 
They were then instructed and verbally encouraged to 
perform 30 maximal knee extensions consecutively and 
throughout the preset full range of movement.28 Subjects 
were instructed to avoid any muscle effort during return 
of the leg to the resting position. They performed two tri-
als in a randomized order, one at each angular velocity, 
ie, 90° and 180° per second, each separated by a 1-hour 
resting period.
Data for the first contraction were systematically excluded 
from all analyses, since the starting maneuver is often 
submaximal. Peak torque was determined from the highest 
torque measured in 30 contractions. Isokinetic muscle endur-
ance was defined as total muscle work developed in all con-
tractions. Muscle fatigue was assessed using both the fatigue 
index and the work slope. The fatigue index was determined 
from the ratio of the work performed during the last ten repeti-
tions to the work performed during the first ten repetitions,14 
and the work slope was quantified from the decline in muscle 
work over time throughout the 30 repetitions.21
effort perception
Perception of dyspnea and leg fatigue was measured using 
the modified Borg scale (0–10) of perceived exertion29 and 
is reported as the change in scores before and immediately 
after completion of each isokinetic endurance test (∆ dyspnea 
and ∆ leg fatigue).
statistical analysis
Descriptive statistics are reported for subject characteris-
tics and for isokinetic total work, isokinetic work slope, 
muscle fatigue index, ∆ dyspnea, and ∆ leg fatigue at each 
visit. The data are expressed as the mean ± standard devia-
tion. For each subject, comparisons between two isokinetic 
endurance tests at two angular velocities were performed 
using a mixed linear model with a hierarchical structure. 
Results were considered to be statistically significant when 
the P-value was #0.05. Test-retest reliability was assessed 
with ICC30 for peak torque, muscle endurance (total work), 
rate of decline in muscle work (work slope), fatigue index, 
∆ dyspnea, and ∆ leg fatigue, and for each velocity separately. 
In order to facilitate clinical interpretation of the reliability 
results, MDC values at the 95% confidence level, both in 
absolute (MDC
95%
) and relative (MDC
95% 
[%]) terms, were cal-
culated from the standard error of measurement (SEM) using 
the following formulae described by Beckerman et al:31
 MDC SEM
95
2
%
= ×1.96 ×  
 MDC
MDC
Mean of  visits95
95
2
100
%
%%( ) = ×  
Finally, between-measurement limits of agreement were 
established using a Bland and Altman32 representation for 
both angular velocities. The proportion of scores at two 
standard deviations of the mean difference between test-retest 
values was taken as a parameter of agreement.
The statistical analyses were performed using the statis-
tical packages R version 3.0.2. (R Foundation for Statisti-
cal Computing, Vienna, Austria.), SAS version 9.4 (SAS 
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Institute Inc, Cary, NC, USA), Statistical Package for the 
Social Sciences version 22 software (IBM Corporation, 
Armonk, NY, USA) or GraphPad Prism version 6 for Mac 
OS X (GraphPad Software, San Diego, CA, USA, www.
graphpad.com).
Results
Subject characteristics are presented in Table 1. Fourteen 
sedentary patients with COPD (78% men) completed the 
study. Except for one subject for whom an additional trial at 
180° per second was necessary, all participants required only 
one practice session for familiarization with the isokinetic 
testing procedure. In agreement with randomization, eight 
participants began with the endurance test performed at 
180° per second and six began at 90° per second for the first 
visit, and the order of test administration was reversed for 
the second visit. Peak torque, total isokinetic work, muscle 
fatigue, and delta rating of dyspnea and leg fatigue for each 
endurance trial and visit at both velocities (90° and 180° 
per second) are shown in Table 2. As expected, statistically 
significant differences in these variables were noted between 
the two angular velocities (P,0.05).
Table 3 shows the ICC and MDC for the two quadriceps 
endurance testing protocols. At 90° per second, an ICC .0.90 
was found for peak torque, total isokinetic work, work slope, 
and work fatigue index. In contrast, at 180° per second, peak 
torque and total isokinetic work were the only parameters 
with an ICC .0.75. The MDC
95% 
(%) for peak force at 90° 
and 180° per second were 12% and 19%, respectively. The 
MDC
95% 
(%) for total isokinetic work measurements at 90° 
and 180° per second was 10% and 19%, respectively. The 
MDC
95% 
(%) for work slope showed poor reliability at both 
velocities. However, the work fatigue index measurements 
were considered reliable only at 90° per second, with a 
MDC
95% 
(%) of 13%, in comparison with 85% at 180° per sec-
ond. Measurements of perception of dyspnea and leg fatigue 
were poorly reliable, with an ICC ,0.65 and MDC
95%
 (%) 
.70% irrespective of muscle contraction velocity.
Limits of agreement, by Bland-Altman plots, are pre-
sented in Figure 2A–L. Better between-visits reliability, 
expressed as a percentage of difference (bias ± random 
error) was found for muscle endurance at 90° per second 
when compared with 180° per second (-2.6%±10.1% and 
5.4%±19.7%, respectively). Similar results were found for 
work slope and work fatigue index, with 95% confidence 
interval limits of agreement much wider at 180° per second, 
implying a lower reliability for these measurements at this 
velocity. Bland-Altman plots for dyspnea and leg fatigue 
scores clearly illustrate a high between-visits variability in 
changes.
Discussion
The major finding of this study was that a 30-maximum rep-
etition isokinetic muscle endurance test can be performed in a 
reliable fashion in sedentary patients with moderate to severe 
COPD and similar body composition, particularly at 90° per 
second. While isokinetic peak torque and total muscle work 
Table 1 subject characteristics (n=14)
Male/female 11/3
age (years) 65±4
Body mass index (kg/m2) 26.6±3.9
Fat-free mass index (kg/m2) 18.6±1.7
FVC (l) 3.6±1.1
FVC (% predicted) 97±25
FeV1 (l) 1.51±0.59
FeV1 (% predicted) 55±18
FeV1/FVC (%) 42±10
TlC (l) 7.1±1.8
TlC (% predicted) 117±10
DlCO (% predicted) 64±16
spO2 (%) 96±1
Physical activity (Voorrips score) 5±5
Note: Values are shown as the mean ± standard deviation.
Abbreviations: FVC, forced vital capacity; FeV1, forced expiratory volume in 
1 second; TlC, total lung capacity; DlCO, diffusing capacity of the lung for carbon 
monoxide; spO2, pulse oximetry oxygen saturation.
Table 2 Comparison between variables of the lower limb isokinetic endurance test at different angular velocities
Variables 90° per second 180° per second*
Visit 1 Visit 2 Visit 1 Visit 2
Peak torque (nm) 115±30 118±33 89±26 89±25
Total isokinetic work (nm) 2,164±553 2,214±535 1,712±508 1,803±514
Work slope (%/rep) -2.4±0.8 -2.5±0.9 -1.5±0.7 -1.3±0.6
Fatigue index (%) 49.3±8.2 49.5±7.9 40.1±13.0 35.4±14.7
Delta dyspnea (Borg scale) 3±2 3±1 2±1 3±1
Delta leg fatigue (Borg scale) 5±3 6±2 4±2 5±1
Notes: Values are shown as the mean ± standard deviation. *P,0.05 180° per second vs 90° per second.
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Table 3 Test-retest reliability
Variables 90° per second 180° per second
ICC (95% CI) MDC95% MDC95% (%) ICC (95% CI) MDC95% MDC95% (%)
Peak torque 0.97 (0.92–0.99) 14 nm 12 0.94 (0.81–0.98) 17 nm 19
Total isokinetic work 0.98 (0.93–0.99) 220 nm 10 0.93 (0.78–0.98) 339 nm 19
Work slope 0.94 (0.83–0.98) 0.58%/rep 23 0.59 (0.13–0.85) 1.21%/rep 86
Work fatigue index 0.92 (0.77–0.97) 6.5% 13 0.30 (-0.24–0.70) 32.2% 85
∆ Dyspnea 0.51 (-0.03–0.81) 3 118 0.24 (-0.26–0.66) 3 121
∆ leg fatigue 0.51 (-0.02–0.81) 5 86 0.60 (0.15–0.85) 3 75
Abbreviations: CI, confidence level; ICC, intraclass correlation; MDC, minimal detectable change; MDC95%, absolute value of MDC at the 95% CI; MDC95% (%), relative 
value of MDC at the 95% CI; rep, repetition.
were highly reliable at angular velocities of 90° and 180° per 
second, test-retest measurements of work slope and fatigue 
index were only reproducible at 90° per second.
Changes in dyspnea and leg fatigue perception scores 
failed to achieve acceptable test-retest reproducibility, irre-
spective of the velocity applied. Therefore, their assessment 
in this isokinetic endurance test is of uncertain significance. 
Overall, our results have practical implications for develop-
ment of endurance muscle testing in patients with COPD, an 
area for which no standardization is available.
To our knowledge, this is the first study to provide a 
MDC and to report on comparison of the reliability of quad-
riceps muscle endurance indices at two angular velocities 
commonly used to assess muscle endurance and fatigue in 
isokinetic protocols in COPD. Typically, in comparison with 
healthy controls, patients with COPD are found to present 
lower isometric torque and total work.33,34
Results for the ICC analyses, MDC, and Bland-Altman 
plots all show that a velocity of 90° per second provides 
more robust data than a faster velocity of 180° per second. 
These findings are consistent with a previous study involving 
healthy subjects that reported a much lower reliability for 
muscle fatigue indices in a similar 30 repetitions trial at 180° 
per second than at 60° per second.14 The higher reliability for 
endurance (total isokinetic work) compared with the fatigue 
index observed in our study is also in line with previous stud-
ies in healthy subjects that consistently found the strongest 
and most reliable measures of isokinetic endurance were total 
isokinetic work and average power, irrespective of angular 
velocity.12,14,35,36 In those studies, low reliability was found for 
work slope or fatigue index.
There are several potential explanations for the higher 
reliability at lower contraction velocity observed in our 
study. Muscle can produce greater dynamic torque during an 
isokinetic maneuver when contracting slowly rather than at 
faster velocities.37,38 This could be explained by difficulties in 
fully activating the available motor units by voluntary effort 
over the whole range of motion or in the brief time required 
for full knee extension at faster speeds of contraction.37,38 
In addition, elderly individuals show significant deficiencies 
in functional performance39 and typically do not produce fast 
contractions in daily life. This could contribute to a reduction 
in their torque production and total work using a high velocity 
protocol. Lastly, despite our effort to minimize the impact 
of any learning effects with a rigorous familiarization visit, 
it is still possible that patients may not have become fully 
accustomed to the high velocity protocol.
From perceptual and symptomatic perspectives, our data 
show that the variations in dyspnea and leg fatigue scores 
induced by the isokinetic endurance protocol were not reli-
able between the two visits at either velocity. Values obtained 
from the MDC
95% 
regarding variation in dyspnea showed ±3 
points in Borg scale variability, which represents more than 
half the range of the scale. Similar results were observed for 
leg fatigue. The reliability of the Borg ratings of perceived 
exertion during exercise has already been challenged in 
numerous publications involving healthy subjects40,41 and 
patients with COPD.42 In a study by Mador et al42 evaluating 
six patients with moderate to severe COPD during weekly 
symptom-limited maximal incremental exercise on a cycle 
ergometer, it was estimated that an individual subject’s 
maximum Borg score would need to change by 36% or more 
before a significant change from baseline could be inferred. 
On the contrary, in multicenter trials involving 463 COPD 
patients, O’Donnell et al43 demonstrated an ICC of 0.79 
(0.76–0.82) for Borg dyspnea ratings at isotime exercise 
and of 0.81 (0.77–0.84) at peak exercise during two repeated 
cycling exercises. To our knowledge, the reliability of the 
modified Borg dyspnea scale has not been assessed in any 
endurance isokinetic protocol involving patients with COPD. 
The reasons for this apparent discrepancy in the reliability of 
dyspnea rating between isokinetic muscle testing and cycling 
exercise are unclear. It may well be that the type of exercise, 
with cycling exercise inducing a larger degree of dyspnea 
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Figure 2 Bland-altman plots.
Notes: llustration by Bland-Altman plots of means differences (solid lines) and 95% confidence intervals (dotted lines) of a 30-maximal repetition isokinetic muscle endurance 
procedure performed on two separate occasions for peak torque, total work, work slope, work fatigue, dyspnea perception, and leg fatigue perception. left panels illustrate 
means differences and 95% confidence intervals for peak torque (A), total work (C), work slope (E), work fatigue (G), dyspnea perception (I), and leg fatigue perception 
(K) during isokinetic leg extension performed at 90°/s. The right panels illustrate means differences and 95% confidence intervals for peak torque (B), total work (D), work 
slope (F), work fatigue (H), dyspnea perception (J), and leg fatigue perception (L) during isokinetic leg extension performed at 180°/s.
Abbreviation: sD, standard deviation.
(typically 5–6 points on a 10-point Borg scale) than isokinetic 
muscle testing (2–3 points) in the present study, exerts much 
influence on the reliability of this dyspnea scale.
It could be argued that a limitation of our study is the 
relatively small sample size. However, several factors favor 
its external validity for a precise population of patients with 
COPD. Firstly, the sample size was determined to test the 
hypothesis that, for both velocities, muscle endurance and 
work fatigue indices would achieve minimally acceptable reli-
ability, such as defined by an ICC .0.6.17 Moreover, increas-
ing the sample size does not necessarily change reliability. 
A study involving a healthy larger population demonstrated 
that reliability, measured by Pearson correlation coefficients, 
may be more affected by similarities between subjects than 
by the sample size.44 This study, including 176 subjects, led 
to an ICC .0.7, which was clinically acceptable. Taking into 
account the complexity of phenotypes commonly found in 
COPD, we restricted our study population to a very homoge-
nous sample in terms of severity of disease, body composition, 
and level of physical activity. Additionally, a separate famil-
iarization session was provided to minimize within-session 
learning effects. Accordingly to Walter et al17 with 14 subjects 
performing two observations for each velocity, this study is 
adequately powered to demonstrate the minimally acceptable 
reliability in a homogenous population.
It would have been of interest to test the reliability of the 
muscle endurance protocols separately in men and women. 
Although this could not be done in our study, we found that 
excluding the three women from the analysis did not alter 
the conclusions about the reliability of the measurements. 
Additionally, subjects’ baseline muscular condition might 
have been different between visits, potentially influencing 
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our conclusions concerning the reliability of the measure-
ments. However, the close similarity in maximal peak 
torque measurements on subsequent testing days suggests 
similar baseline conditions between visits and no impact 
of the fatigue induced by the 30 maximal contractions in 
the first set on performance during the second test in the 
same visit.
Several studies have reported on quadriceps endur-
ance in COPD using a variety of methodologies, including 
measurement of time to sustain submaximal voluntary 
contractions at a preset proportion of submaximal volun-
tary contractions using weights,6,7,45–47 a strain gauge,48 or a 
dynamometer,5 quantification of the number of contractions 
or fatigue index using an isokinetic protocol,49 and time 
taken for quadriceps strength to fall to a certain threshold 
following repeated magnetic stimulation of the femoral 
nerve.3 Collectively, these studies clearly show that lower 
limb muscle endurance is reduced in COPD in comparison 
with healthy controls of similar age and that muscle endur-
ance is compromised to a larger extent than strength.5,7 
These studies also illustrate the relationship between endur-
ance and oxidative capacity.3,48 Altogether, these studies 
provide a strong rationale for the relevance of measuring 
muscle endurance in COPD.
Despite the interest in quantifying muscle endurance, 
this parameter has not been incorporated into clinical prac-
tice. In this regard, the diversity of protocols is a reflection 
of the absence of standardization and highlights a need 
to develop standardized, simple, but valid and sensitive 
endurance knee extensor procedures to be used in usual 
clinical settings in patients with COPD. Also, the lack of 
consensus with regard to designation of the best testing 
protocol to evaluate muscle endurance and the absence of 
predictive values are other impediments to the widespread 
application of this measurement. The concise protocol that 
we report here has the advantage of feasibility in patients 
with COPD in regard to their cardiorespiratory limitation, 
relative simplicity, and reproducibility, allowing measure-
ment of maximal muscle torque, total work, and work 
slope using only one procedure. The good reproducibility 
of isokinetic protocols relates to the control of speed of 
contraction, an important variable in transforming muscle 
contractions into work. Potential disadvantages of an 
isokinetic protocol are related to cost, availability of the 
testing apparatus, and the need for a technician specifi-
cally training in use of the isokinetic device. The external 
validity of this measurement has also been questioned, 
since constant angular velocity is not a physiological 
movement.50 Standardized position, time of day and rest 
intervals are recognized to affect  the test-retest reliability 
of an isokinetic procedure.51 Thus, familiarization and strict 
standardization of testing procedures are crucial to provid-
ing accurate assessments of limb muscle function.52,53 Not-
withstanding these considerations, an endurance isokinetic 
protocol using 30 maximal contractions provides reliable 
data, an essential feature for accurate assessment of the 
effects of therapeutic interventions designed to improve 
muscle performance.
From a clinical perspective, a minimally detectable 
change of 10% for total work measurements at an angular 
velocity of 90° per second compares favorably with a cor-
responding value of 6%–12.2% for quadriceps strength 
measurements.54,55 Therefore, our isokinetic protocol at 90° 
per second appears as reliable as a more widely used and 
accepted parameter of muscle function such as strength. 
The isokinetic protocol also provides reliable assessment of 
peak torque and fatigue index. Based on the present results, 
a 10%–15% or greater change in peak torque, total isokinetic 
work, and fatigue index at 90° per second following a given 
therapeutic intervention should be considered confidently as 
a true treatment effect.
Conclusion
Despite a small sample size, our findings support the use 
of a 30-maximum repetitions isokinetic muscle testing 
procedure at an angular velocity of 90° and 180° per second 
in sedentary patients with moderate to severe COPD and 
similar body composition. Measurement of total isokinetic 
work using an angular velocity of 90° per second was 
highly reliable, with a MDC
95% 
(%) value of 10%, mak-
ing it a procedure of choice for evaluation of quadriceps 
endurance in this population. Furthermore, peak torque 
and fatigue index could also be assessed reliably at 90° 
per second. Evaluation of dyspnea and leg fatigue using 
the modified Borg scale of perceived exertion was poorly 
reliable and its clinical usefulness is questionable. These 
results should be useful in the design and interpretation of 
future interventions aimed at improving muscle endurance 
in COPD.
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